|FDA Stops Being Antisocial - Recent Social Media Guidance Breaks the Silence|
On January 13, FDA released long-awaited guidance on using social media to promote prescription drugs. The guidance outlines FDA’s expectations for when and how a company should submit such “interactive promotional media” to the agency pursuant to postmarketing submission requirements.
During this 1-hour complimentary webinar, AGG's Food and Drug Practice leader, Alan Minsk, and associate, Kelley Nduom, addressed questions such as:
- Who influences or controls the message?
- When should I submit a 2253?
- Am I responsible if someone comments on our website?
- What do we need to do differently?